1. (1) The board may exchange monitored prescription drug history reports and PDMP data with a prescription monitoring program operated by a relevant agency in another state or jurisdiction if the prescription monitoring program satisfies all of the following conditions:

   1. (a) The prescription monitoring program is compatible with the program.
   2. (b) The relevant agency operating the prescription monitoring program agrees to exchange similar information with the program.

2. (2) In determining the compatibility of a prescription monitoring program to the program, the board may consider any of the following:

   1. (a) The safeguards for privacy of patient records and the prescription monitoring program’s success in protecting patient privacy.
   2. (b) The persons authorized to access the information stored by the prescription monitoring program.
   3. (c) The schedules of controlled substances monitored by the prescription monitoring program.
   4. (d) The information required by the agency to be submitted regarding the dispensing of a prescription drug.
   5. (e) The costs and benefits to the board of sharing information.
3. (3) The board may assess a prescription monitoring program’s continued compatibility with the program at any time.

History

History: CR 12-009: cr. Register October 2012 No. 682, eff. 1-1-13; CR 14-003: am. (1) (intro.) Register August 2014 No. 704, eff. 9-1-14; EmR1706: emerg. am. (title), (1) (intro.), eff. 4-1-17; CR 17-028: am. (title), (1) (intro.) Register December 2017 No. 744, eff. 1-1-18.